1. A phase II study of atezolizumab for pretreated advanced/recurrent non-small cell lung cancer with idiopathic interstitial pneumonias: rationale and design for the TORG1936/AMBITIOUS study. (May 2020) Authors: Ikeda, Satoshi; Kato, Terufumi; Kenmotsu, Hirotsugu; Ogura, Takashi; Iwasawa, Shunichiro; Iwasawa, Tae; Kasajima, Rika; Miyagi, Yohei; Misumi, Toshihiro; Yamanaka, Takeharu; Okamoto, Hiroaki Journal: Therapeutic advances in medical oncology Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Repeated Biopsy by EBUS-TBNA Contributed to the Selection of an Appropriate Therapeutic Regimen for a Lung Cancer Patient. Issue 2 (April 2019) Authors: Naito, Jun; Toyoda, Takahide; Nakajima, Takahiro; Fujiwara, Taiki; Iwasawa, Shunichiro; Suzuki, Hidemi; Takiguchi, Yuichi; Yoshino, Ichiro Journal: Journal of bronchology & interventional pulmonology Issue: Volume 26:Issue 2(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial. Issue 1 (January 2022) Authors: Kawashima, Yosuke; Fukuhara, Tatsuro; Saito, Haruhiro; Furuya, Naoki; Watanabe, Kana; Sugawara, Shunichi; Iwasawa, Shunichiro; Tsunezuka, Yoshio; Yamaguchi, Ou; Okada, Morihito; Yoshimori, Kozo; Nakachi, Ichiro; Seike, Masahiro; Azuma, Koichi; Kurimoto, Futoshi; Tsubata, Yukari; Fujita, Yuka; Nag... Journal: Lancet Issue: Volume 10:Issue 1(2022) Page Start: 72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical characteristics and risk factors of drug‐induced lung injury by ALK tyrosine kinase inhibitors: A single center retrospective analysis. Issue 6 (1st April 2020) Authors: Koshikawa, Ken; Terada, Jiro; Abe, Mitsuhiro; Iwasawa, Shunichiro; Sakayori, Masashi; Yoshioka, Keiichiro; Hirasawa, Yasutaka; Kasai, Hajime; Kawasaki, Yohei; Tsushima, Kenji; Tatsumi, Koichiro Journal: Thoracic cancer Issue: Volume 11:Issue 6(2020) Page Start: 1495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial. Issue 5 (May 2019) Authors: Saito, Haruhiro; Fukuhara, Tatsuro; Furuya, Naoki; Watanabe, Kana; Sugawara, Shunichi; Iwasawa, Shunichiro; Tsunezuka, Yoshio; Yamaguchi, Ou; Okada, Morihito; Yoshimori, Kozo; Nakachi, Ichiro; Gemma, Akihiko; Azuma, Koichi; Kurimoto, Futoshi; Tsubata, Yukari; Fujita, Yuka; Nagashima, Hiromi; Asai... Journal: Lancet oncology Issue: Volume 20:Issue 5(2019) Page Start: 625 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Feasibility study of first-line chemotherapy using Pemetrexed and Bevacizumab for advanced or recurrent nonsquamous non-small cell lung cancer in elderly patients: TORG1015. Issue 1 (December 2016) Authors: Kozuki, Toshiyuki; Nogami, Naoyuki; Kitajima, Hiromoto; Iwasawa, Shunichiro; Sakaida, Emiko; Takiguchi, Yuichi; Ikeda, Satoshi; Yoshida, Masahiro; Kato, Terufumi; Miyamoto, Shingo; Sakamaki, Kentaro; Shinkai, Tetsu; Watanabe, Koshiro Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Prognostic Factors and Efficacy of First‐Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study. (23rd March 2018) Authors: Ko, Ryo; Shukuya, Takehito; Okuma, Yusuke; Tateishi, Kazunari; Imai, Hisao; Iwasawa, Shunichiro; Miyauchi, Eisaku; Fujiwara, Akiko; Sugiyama, Tomohide; Azuma, Keisuke; Muraki, Keiko; Yamasaki, Masahiro; Tanaka, Hisashi; Takashima, Yuta; Soda, Sayo; Ishimoto, Osamu; Koyama, Nobuyuki; Morita, Satos... Journal: Oncologist Issue: Volume 23:Number 10(2018) Page Start: 1210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Prognostic factors for patients with metastatic or recurrent thymic carcinoma receiving palliative-intent chemotherapy. (October 2020) Authors: Okuma, Yusuke; Ko, Ryo; Shukuya, Takehito; Tateishi, Kazunari; Imai, Hisao; Iwasawa, Shunichiro; Miyauchi, Eisaku; Kojima, Tetsuya; Fujita, Yuka; Hino, Toshihiko; Yamanda, Shinsuke; Suzuki, Toshiro; Fukuizumi, Aya; Sakakibara, Tomohiro; Harada, Toshiyuki; Morita, Satoshi; Kobayashi, Kunihiko; Nuk... Journal: Lung cancer Issue: Volume 148(2020) Page Start: 122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Prophylactic dexamethasone for radiation-induced bone-pain flare. Issue 2 (February 2016) Authors: Ishiwata, Tsukasa; Iwasawa, Shunichiro; Kurimoto, Ryota; Ebata, Takahiro; Takiguchi, Yuichi Journal: Lancet oncology Issue: Volume 17:Issue 2(2016:Feb.) Page Start: e39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Real-world survey of pneumonitis and its impact on durvalumab consolidation therapy in patients with non-small cell lung cancer who received chemoradiotherapy after durvalumab approval (HOPE-005/CRIMSON). (November 2021) Authors: Saito, Go; Oya, Yuko; Taniguchi, Yoshihiko; Kawachi, Hayato; Daichi, Fujimoto; Matsumoto, Hirotaka; Iwasawa, Shunichiro; Suzuki, Hidekazu; Niitsu, Takayuki; Miyauchi, Eisaku; Yokoi, Takashi; Yokoyama, Toshihide; Uenami, Takeshi; Sakata, Yoshihiko; Arai, Daisuke; Okada, Asuka; Nagata, Kenji; Terao... Journal: Lung cancer Issue: Volume 161(2021) Page Start: 86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗